These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6608779)

  • 21. Natural history of chronic type B hepatitis.
    Hoofnagle JH; Seeff LB
    Prog Liver Dis; 1982; 7():469-79. PubMed ID: 7111756
    [No Abstract]   [Full Text] [Related]  

  • 22. [General aspects of management and immunosuppressive therapy of chronic active hepatitis].
    Tareev EM; Aprosina ZG
    Ter Arkh; 1980; 52(4):7-13. PubMed ID: 7404343
    [No Abstract]   [Full Text] [Related]  

  • 23. Liver transplantation in hepatitis B surface antigen positive patients with postoperative long-term immunoprophylaxis.
    Langrehr JM; Lemmens HP; Keck H; Lohmann R; Knoop M; Neumann U; Müller AR; Platz KP; Kling N; Hopf U
    Transplant Proc; 1995 Feb; 27(1):1215-6. PubMed ID: 7533373
    [No Abstract]   [Full Text] [Related]  

  • 24. [Efficacy of Phyllanthus spp. in treating patients with chronic hepatitis B].
    Wang MX; Cheng HW; Li YJ; Meng LM; Mai K
    Zhongguo Zhong Yao Za Zhi; 1994 Dec; 19(12):750-1, 764. PubMed ID: 7718142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B.
    Eggink HF; Houthoff HJ; Huitema S; Wolters G; Poppema S; Gips CH
    Clin Exp Immunol; 1984 Apr; 56(1):121-8. PubMed ID: 6713726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Unexpected regression of chronic hepatitis type B after a long-term course].
    Procházka V; Pohlídalová L
    Cas Lek Cesk; 1983 Sep; 122(38):1165-71. PubMed ID: 6627342
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prognostic value of HBe antigen and anti-HBe antibody in viral hepatitis B (author's transl)].
    Chossegros P; Trepo C; Brette R; Chevallier P; Vitviski L; Sepetjan M
    Nouv Presse Med; 1981 May; 10(24):1993-6. PubMed ID: 7255135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Incidence of antibody against hepatitis B core antigen (anti-HBc) in chronic diffuse liver diseases].
    Dávid K; Halmy L
    Orv Hetil; 1983 Apr; 124(15):879-84. PubMed ID: 6856288
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis].
    Hinoue Y; Unoura M; Kato Y; Kobayashi K; Hattori N
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):205-11. PubMed ID: 6696458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical problems of chronic hepatitis].
    Bliuger AF
    Klin Med (Mosk); 1980 Sep; 58(9):16-23. PubMed ID: 6997608
    [No Abstract]   [Full Text] [Related]  

  • 31. A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B.
    Kato J; Hasegawa K; Torii N; Yamauchi K; Hayashi N
    Hepatology; 1996 Mar; 23(3):389-95. PubMed ID: 8617416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunosuppressive therapy in patients with HBeAg-positive chronic active hepatitis B?].
    Maier KP; Lepiorz H; Berthold H; Gerok W
    Leber Magen Darm; 1982 Aug; 12(4):150-3. PubMed ID: 7132529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Levamisole in the therapy of viral hepatitis B].
    Farber NA; Ketiladze ES; Kamilov FKh; Ambrozaĭtis AK; Braginskiĭ DM
    Ter Arkh; 1983; 55(9):121-5. PubMed ID: 6605591
    [No Abstract]   [Full Text] [Related]  

  • 34. [Glucocorticoids in therapy of HBs-positive viral hepatitis].
    Mansurov KhKh; Eĭtsen EF; Mirodzhov GK
    Ter Arkh; 1981; 53(10):97-101. PubMed ID: 7313973
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of immunosuppressive therapy on hepatic expression of hepatitis B viral genome and gene products.
    Lau JY; Bird GL; Alexander GJ; Williams R
    Clin Invest Med; 1993 Jun; 16(3):226-36. PubMed ID: 8365050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunosuppressive therapy of chronic aggressive hepatitis].
    Schimmelpfennig W; Wagner K; Theuer D; Schneider G
    Z Gesamte Inn Med; 1973 Jun; 28(12):Suppl:177-8 f. PubMed ID: 4729270
    [No Abstract]   [Full Text] [Related]  

  • 37. Recent developments in the diagnosis and monitoring of HBV infection and role of the genetic variability of the S gene.
    Weber B
    Expert Rev Mol Diagn; 2005 Jan; 5(1):75-91. PubMed ID: 15723594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute irreversible rejection after withdrawal of azathioprine in renal allograft recipients.
    Shiramizu T; Nakamura K; Hida M; Shinbo T; Nakayama M; Saitoh H; Satoh T; Hata J; Tsuji K
    Tokai J Exp Clin Med; 1981 Jul; 6(3):315-9. PubMed ID: 7029783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The HBs antigen in asymptomatic chronic hepatitis B].
    Gerken G
    Dtsch Med Wochenschr; 1993 Feb; 118(5):163. PubMed ID: 8432238
    [No Abstract]   [Full Text] [Related]  

  • 40. Interferon-gamma (IFN-gamma) response to different hepatitis B virus antigens in hepatitis B virus infection.
    Paul S; Tabassum S; Islam MN
    Bangladesh Med Res Counc Bull; 2004 Aug; 30(2):71-7. PubMed ID: 15813485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.